Syneos eyes ocular trials with new catalyst site network

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/dolgachov)
(Image: Getty/dolgachov)
Syneos Health has launched a Catalyst Ophthalmology Site Network to support startup and delivery of ocular clinical trials.

The Ophthalmology Site Network currently includes 24 sites across the US and Europe.

Participation in the network, which is expected to grow to more than 30 sites globally in the coming months, is by invitation only.

According to the Syneos, members have the opportunity to participate in an increased volume of ophthalmology-related trials. Additionally, sites receive a dedicated relationship manager.

The Ophthalmology Site Network also will include fully integrated central institutional review board (IRB) and reading center services.

With the addition of the newest network, the company’s Catalyst Site Program – launched in 2016 – now includes more than 100 sites across the US, UK, and APAC.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us

Products

View more

Webinars